Call to 'suspend' diabetes drug (BBC News, 23 September 2010)
The European Medicines Agency has recommended that marketing authorisation for the diabetes drug Avandia (generic name rosiglitazone) be suspended following a review of data on the drug's cardiovascular side-effects.
Full article